Demetri George

CIK 00016391473 companiesCAMBRIDGE, MA

SEC Profile

Transactions

Companies

Filings

CIK

0001639147

Recent Transactions

39 trades

Award
Blueprint Medicines Corp
Common Stock
2022-06-21+2,600→ 8,412 total
Award
Blueprint Medicines Corp
Stock Option (Right to Buy)
2022-06-21+5,300→ 5,300 total
Sale
Blueprint Medicines Corp
Common Stock
2022-03-17$58.56/sh−10→ 5,812 total
Sale
Translate Bio, Inc.
Stock Option (right to buy)
2021-09-14−37,800→ 0 total
Sale
Translate Bio, Inc.
Stock Option (right to buy)
2021-09-14−18,900→ 0 total
Sale
Translate Bio, Inc.
Stock Option (right to buy)
2021-09-14−20,000→ 0 total
Sale
Translate Bio, Inc.
Stock Option (right to buy)
2021-09-14−18,900→ 0 total
Sale
Translate Bio, Inc.
Stock Option (right to buy)
2021-09-14−20,000→ 0 total
Sale
Translate Bio, Inc.
Stock Option (right to buy)
2021-09-14−37,800→ 0 total
Purchase
Blueprint Medicines Corp
Common Stock
2021-07-13$82.66/sh+10→ 5,822 total
Award
Translate Bio, Inc.
Stock Option (right to buy)
2021-06-16+20,000→ 20,000 total
Award
Blueprint Medicines Corp
Common Stock
2021-06-02+2,250→ 5,812 total
Award
Blueprint Medicines Corp
Stock Option (Right to Buy)
2021-06-02+4,500→ 4,500 total
Sale
Blueprint Medicines Corp
Common Stock
2021-01-04$112.15/sh−758→ 3,562 total
Sale
Blueprint Medicines Corp
Common Stock
2020-09-22$85.00/sh−1,704→ 4,320 total
Award
Blueprint Medicines Corp
Stock Option (Right to Buy)
2020-06-24+4,500→ 4,500 total
Award
Blueprint Medicines Corp
Common Stock
2020-06-24+2,250→ 6,024 total
Exercise/Conversion
Blueprint Medicines Corp
Common Stock
2020-06-19+1,312→ 3,774 total
Exercise/Conversion
Blueprint Medicines Corp
Restricted Stock Units
2020-06-19−1,312→ 0 total
Award
Translate Bio, Inc.
Stock Option (right to buy)
2020-06-16+18,900→ 18,900 total
Sale
Blueprint Medicines Corp
Common Stock
2020-01-10$85.00/sh−568→ 2,462 total
Sale
Blueprint Medicines Corp
Common Stock
2020-01-07$80.59/sh−1,705→ 3,030 total
Award
Translate Bio, Inc.
Stock Option (right to buy)
2019-07-12+37,800→ 37,800 total
Award
Blueprint Medicines Corp
Stock Option (Right to Buy)
2019-06-19+4,875→ 4,875 total
Award
Blueprint Medicines Corp
Restricted Stock Units
2019-06-19+1,312→ 1,312 total
Sale
Blueprint Medicines Corp
Common Stock
2019-06-17$96.99/sh−568→ 5,303 total
Sale
Blueprint Medicines Corp
Common Stock
2019-06-17$100.00/sh−568→ 4,735 total
Sale
Blueprint Medicines Corp
Common Stock
2019-06-13$90.00/sh−568→ 5,871 total
Award
Blueprint Medicines Corp
Stock Option (Right to Buy)
2018-06-21+7,500→ 64,771 total
Award
MERRIMACK PHARMACEUTICALS INC
Stock Option (right to buy)
2018-06-13+7,000→ 7,000 total
Sale
Blueprint Medicines Corp
Common Stock
2018-03-19$99.06/sh−1,200→ 6,439 total
Sale
Blueprint Medicines Corp
Common Stock
2018-03-19$100.04/sh−2,592→ 7,639 total
Sale
Blueprint Medicines Corp
Common Stock
2018-03-19$100.88/sh−1,700→ 10,231 total
Sale
Blueprint Medicines Corp
Common Stock
2018-02-27$89.48/sh−200→ 17,781 total
Sale
Blueprint Medicines Corp
Common Stock
2018-02-27$87.85/sh−2,765→ 11,931 total
Sale
Blueprint Medicines Corp
Common Stock
2018-02-27$90.68/sh−200→ 17,981 total
Sale
Blueprint Medicines Corp
Common Stock
2018-02-27$88.45/sh−3,085→ 14,696 total
Award
MERRIMACK PHARMACEUTICALS INC
Stock Option (right to buy)
2017-12-14+4,890→ 4,890 total
Award
Blueprint Medicines Corp
Stock Option (Right to Buy)
2017-06-21+10,909→ 57,271 total

Companies

Recent Filings

Address

C/O MERRIMACK PHARMACEUTICALS, INC. ONE KENDALL SQUARE, SUITE B7201

CAMBRIDGE, MA, 02139

View on SEC.gov